Skip to main content

Advertisement

SpringerLink
Log in

Five-year outcomes of ab interno Xen 45 gel stent implantation

  • Glaucoma
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To assess the safety and 5-year efficacy of ab interno XEN 45 gel stent implantation with phacoemulsification in primary open-angle glaucoma (POAG).

Methods

Single-centre, single-surgeon, retrospective case note review of consecutive OAG patients who underwent ab-interno gel stent placement combined with phacoemulsification. Surgeries were performed between 2/01/2014 and 2/01/2016. Primary outcome measures: mean reduction in intraocular pressure (IOP) and change in number of ocular hypotensive medications from baseline (follow-up range 1–7 years; mean 54 months). Secondary outcome measure: change in visual field mean deviation (VFMD) from baseline. Safety data included intraoperative and post-operative complications and adverse events. Failure was defined by IOP reduction < 20% despite maximum medical therapy, the need for further laser or surgical intervention. At 5 years, 75% of eyes were free from failure (95% CI 64 to 83%).

Results

Ninety-one eyes were analysed. Mean (SD) IOP and medications decreased from 20.2 (6.4) mmHg and 2.9 (1.0) at baseline to 15.4 (3.6) mmHg (p < 0.001) and 1.5 (1.4) medications at 5 (p < 0.001) years. Baseline mean VFMD (SD) was − 10.3dB (8.5) reducing to − 10.9(8.2) (p < 0.01) at 5 years. Two (2%) eyes had intraoperative complications, 4 (4.3%) experienced post-operative AEs, and 13 (14%) required secondary surgical intervention (SSI).

Conclusion

The gel stent combined with phacoemulsification was effective in reducing IOP and medications over 5 years, with an acceptable safety profile. Visual field change was clinically acceptable through the study period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. American Academy of Ophthalmology (2015) Primary open-angle glaucoma—preferred practice pattern. http://www.aaojournal.org/article/S0161-6420(15)01276-2/pdf. Accessed 23 Nov 2021

  2. European Glaucoma Society Terminology and guidelines for glaucoma (5th edition). https://www.eugs.org/eng/guidelines.asp. Accessed 3 Oct 2021

  3. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group (2001) Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953. https://doi.org/10.1016/S0161-6420(01)00873-9

    Article  CAS  PubMed  Google Scholar 

  4. Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111

    Article  PubMed  Google Scholar 

  5. Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE (2005) Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140:16–22. https://doi.org/10.1016/j.ajo.2005.02.013

    Article  PubMed  Google Scholar 

  6. Zahid S, Musch DC, Niziol LM, Lichter PR (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155:674–680.e1. https://doi.org/10.1016/j.ajo.2012.10.017

    Article  PubMed  Google Scholar 

  7. Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663. https://doi.org/10.1016/j.ophtha.2018.02.003

    Article  PubMed  Google Scholar 

  8. Vera VI, Horvath C (2014) XEN gel stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer Science+Business Media, New York, pp 189–198

    Chapter  Google Scholar 

  9. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE (2011) Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118:459–467. https://doi.org/10.1016/j.ophtha.2010.07.007

    Article  PubMed  Google Scholar 

  10. Denis P, Hirneiß C, Durr GM et al (2022) Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol 106:65–70

    Article  PubMed  Google Scholar 

  11. Caprioli J, Kim JH, Friedman DS etal., (2015) Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC. Ophthalmology 122:1795–1801. https://doi.org/10.1016/j.ophtha.2015.02.029

  12. De Gregorio A, Pedrotti E, Russo L, Morselli S (2017) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38:1129–1134. https://doi.org/10.1007/s10792-017-0571-x

    Article  PubMed  Google Scholar 

  13. Galal A, Bilgic A, Eltanamly R, Osman A (2017) XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol:5457246. https://doi.org/10.1155/2017/5457246

  14. Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I (2017) Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma 26:1130–1136. https://doi.org/10.1097/ijg.0000000000000803

    Article  PubMed  Google Scholar 

  15. Sng CC, Wang J, Hau S, Htoon HM, Barton K (2017) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol 46:339–334. https://doi.org/10.1111/ceo.13087

    Article  PubMed  Google Scholar 

  16. Mansouri K, Guidotti J, Rao HL, Ouabas A, D'Alessandro E, RoyS MA (2018) Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN Gel implant surgery: 1-year results. J Glaucoma 27:140–147. https://doi.org/10.1097/IJG.0000000000000858

    Article  PubMed  Google Scholar 

  17. Tan SZ, Walkden A, Au L (2018) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperativemanagement. Eye 32:324–332. https://doi.org/10.1038/eye.2017.162

    Article  PubMed  Google Scholar 

  18. Gillmann K, Bravetti GE, Mermoud A, Rao HL, Mansouri K (2019) XEN Gel Stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation. J Glaucoma 28:676–684

    Article  PubMed  Google Scholar 

  19. Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257:983–996

    Article  CAS  PubMed  Google Scholar 

  20. Gabbay IE, Allen F, Morley C et al (2020) Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol 104:1125–1130

    Article  PubMed  Google Scholar 

  21. Gillmann K, Bravetti GE, Rao HL et al (2020a) Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors. Acta Ophthalmol. https://doi.org/10.1111/aos.14605

  22. Reitsamer H, Vera V, Ruben S et al (2021) Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multi-centre study. Acta Ophthalmol 100(1):e233–e245. https://doi.org/10.1111/aos.14886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kono Y, Kasahara M, Hirasawa K et al (2020) Long-term clinical results of trabectome surgery in patients with open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 258(11):2467–2476. https://doi.org/10.1007/s00417-020-04897-0

    Article  PubMed  Google Scholar 

  24. Ansari E (2021) 5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma. PloS One 16(9):e0257015. https://doi.org/10.1371/journal.pone.0257015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ziaei H, Au L (2021) Manchester iStent study: long-term 7-year outcomes. Eye 35:2277–2282

    Article  CAS  PubMed  Google Scholar 

  26. Ahmed IIK, De Francesco T, Rhee D et al (2022) HORIZON Investigators. Long-term outcomes from the HORIZON randomized trial for a Schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmol 7:742–751. https://doi.org/10.1016/j.ophtha.2022.02.021

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Maidstone & Tunbridge Wells Hospitals, Kent, UK

    Ejaz Ansari

  2. Institute of Medical Sciences, Canterbury Christ Church University, Kent, UK

    Ejaz Ansari

Authors
  1. Ejaz Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ejaz Ansari.

Ethics declarations

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Maidstone & Tunbridge Wells NHS Trust Research and Development Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

written informed consent was waived by the local Research & Development Committee since the study was retrospective in design with de-identified data collection.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ansari, E. Five-year outcomes of ab interno Xen 45 gel stent implantation. Graefes Arch Clin Exp Ophthalmol 262, 1263–1269 (2024). https://doi.org/10.1007/s00417-023-06294-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-023-06294-9

Keywords

Search

Navigation